The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis

CR Holroyd, R Seth, M Bukhari, A Malaviya… - …, 2019 - academic.oup.com
Christopher R. Holroyd1, Rakhi Seth1, Marwan Bukhari2, Anshuman Malaviya3, Claire
Holmes1, Elizabeth Curtis4, Christopher Chan1, Mohammed A. Yusuf3, Anna Litwic4, 5 …

Comorbidities in rheumatoid arthritis

K Michaud, F Wolfe - Best practice & research Clinical rheumatology, 2007 - Elsevier
Rheumatoid arthritis (RA) is often characterized by the burden of swollen joints, pain, and
decreased physical function, but less understood are the many manifestations of additional …

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium

K Ekström Smedby, CM Vajdic, M Falster… - Blood, The Journal …, 2008 - ashpublications.org
Some autoimmune disorders are increasingly recognized as risk factors for non-Hodgkin
lymphoma (NHL) overall, but large-scale systematic assessments of risk of NHL subtypes …

A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis

AL Smitten, TA Simon, MC Hochberg… - Arthritis research & …, 2008 - Springer
Introduction The risk of malignancies in patients with rheumatoid arthritis (RA) has raised
some concern, particularly with immunosuppressive approaches to disease management …

The effect of methotrexate and anti–tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person‐years of …

F Wolfe, K Michaud - Arthritis & Rheumatism, 2007 - Wiley Online Library
Objective To ascertain the relationship between anti–tumor necrosis factor (anti‐TNF)
therapy, methotrexate (MTX), and the risk of lymphoma in patients with rheumatoid arthritis …

Comorbidities in patients with psoriasis

AB Gottlieb, F Dann - The American journal of medicine, 2009 - Elsevier
Psoriasis is a common chronic inflammatory disease that is associated with serious
comorbidities, including psoriatic arthritis, reduced quality of life, depression, malignancy …

Epidemiology of lymphomas

E Roman, AG Smith - Histopathology, 2011 - Wiley Online Library
Roman E & Smith AG (2011) Histopathology 58, 4–14 Epidemiology of lymphomas
Epidemiological reports on lymphomas often begin, and sometimes end, by stating that little …

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

T Ding, J Ledingham, R Luqmani, S Westlake… - …, 2010 - academic.oup.com
Tina Ding1, Jo Ledingham2, Raashid Luqmani3, Sarah Westlake4, Kimme Hyrich5, Mark
Lunt5, Patrick Kiely6, Marwan Bukhari7, Rikki Abernethy8, Ailsa Bosworth9, Andrew …

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

J Askling, E Baecklund, F Granath, P Geborek… - Annals of the …, 2009 - ard.bmj.com
Background: Tumour necrosis factor (TNF) antagonists have proved effective as treatment
against rheumatoid arthritis (RA), but the unresolved issue of whether the use of anti-TNF …

Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics

KE Smedby, E Baecklund, J Askling - Cancer Epidemiology Biomarkers & …, 2006 - AACR
Certain autoimmune and chronic inflammatory conditions, such as Sjögren's syndrome
and rheumatoid arthritis (RA), have consistently been associated with an increased risk of …